http://www.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2026, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Fri, 13 Mar 2026 16:30:00 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://www.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/SEC+Filings/Form++4++++++++++BiomX+Inc.++++++++++++++++For%3A+Mar+11++Filed+by%3A+Yeganeh+Reuven/26160011.html si-local-file:///var/storage/secattach/20260313/26160011.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++BiomX+Inc.++++++++++++++++For%3A+Mar+11++Filed+by%3A+Yeganeh+Reuven/26160011.html Fri, 13 Mar 2026 16:30:00 -0400 O.39437095 PHGE http://www.streetinsider.com/SEC+Filings/Form++4++++++++++BiomX+Inc.++++++++++++++++For%3A+Mar+11++Filed+by%3A+Yeganeh+Reuven/26160011.html si-local-file:///var/storage/secattach/20260313/26160011.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++BiomX+Inc.++++++++++++++++For%3A+Mar+11++Filed+by%3A+Yeganeh+Reuven/26160011.html Fri, 13 Mar 2026 16:30:00 -0400 O.39437095 PHGE http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++BiomX+Inc.++++++++++++++++For%3A+Mar+11/26146445.html si-local-file:///var/storage/secattach/20260311/26146445.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++BiomX+Inc.++++++++++++++++For%3A+Mar+11/26146445.html Wed, 11 Mar 2026 16:24:00 -0400 O.39437095 PHGE http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++BiomX+Inc.++++++++++++++++For%3A+Mar+11/26146445.html si-local-file:///var/storage/secattach/20260311/26146445.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++BiomX+Inc.++++++++++++++++For%3A+Mar+11/26146445.html Wed, 11 Mar 2026 16:24:00 -0400 O.39437095 PHGE http://www.streetinsider.com/Downgrades/H.C.+Wainwright+Downgrades+BiomX+%28PHGE%29+to+Neutral/26130289.html <p>H.C. Wainwright analyst Joseph Pantginis downgraded BiomX (NYSE: PHGE) from Buy to Neutral.</p><p>The analyst comments "Downgrade to Neutral as programs and path forward currently in limbo. BiomX has had a rough time as of late, and we are downgrading to Neutral from Buy based on the following reasons: · The company's lead program using BX004 in CF has seen volatile news flow, including: o Following positive Phase 2 results in P. aeruginosa infections in CF patients, a Phase 2b was started. o The Phase 2b study http://www.streetinsider.com/Downgrades/H.C.+Wainwright+Downgrades+BiomX+%28PHGE%29+to+Neutral/26130289.html Mon, 09 Mar 2026 10:48:43 -0400 PHGE http://www.streetinsider.com/Analyst+Comments/H.C.+Wainwright+Downgrades+BiomX+%28PHGE%29+to+Neutral/26130289.html <p>H.C. Wainwright analyst Joseph Pantginis downgraded BiomX (NYSE: PHGE) from Buy to Neutral.</p><p>The analyst comments "Downgrade to Neutral as programs and path forward currently in limbo. BiomX has had a rough time as of late, and we are downgrading to Neutral from Buy based on the following reasons: · The company's lead program using BX004 in CF has seen volatile news flow, including: o Following positive Phase 2 results in P. aeruginosa infections in CF patients, a Phase 2b was started. o The Phase 2b study http://www.streetinsider.com/Analyst+Comments/H.C.+Wainwright+Downgrades+BiomX+%28PHGE%29+to+Neutral/26130289.html Mon, 09 Mar 2026 10:48:43 -0400 PHGE http://www.streetinsider.com/Management+Changes/BiomX+appoints+Michael+Oster+as+CEO%2C+David+Rokach+as+CFO/26129711.html <p>BiomX Inc. (NYSE American: PHGE) announced the appointment of Michael Oster as Chief Executive Officer and David Rokach as Chief Financial Officer, according to a company statement.</p> <p>Oster brings experience in corporate strategy, mergers and acquisitions, and operational leadership across energy, infrastructure, and industrial sectors. He currently serves as CEO of Saffron Tech Ltd., an agritech company, and sits on the board of BladeRanger Ltd., a publicly traded Israeli drone payload systems company. Previously, Oster served as Senior Vice President of Mergers and Acquisitions at Alon USA Energy, Inc., leading strategic transactions during the company's growth as a publicly traded energy http://www.streetinsider.com/Management+Changes/BiomX+appoints+Michael+Oster+as+CEO%2C+David+Rokach+as+CFO/26129711.html Mon, 09 Mar 2026 09:00:49 -0400 A.50200987 O.00179827 O.39437095 PHGE http://www.streetinsider.com/Management+Changes/BiomX+appoints+Michael+Oster+as+CEO%2C+David+Rokach+as+CFO/26129711.html <p>BiomX Inc. (NYSE American: PHGE) announced the appointment of Michael Oster as Chief Executive Officer and David Rokach as Chief Financial Officer, according to a company statement.</p> <p>Oster brings experience in corporate strategy, mergers and acquisitions, and operational leadership across energy, infrastructure, and industrial sectors. He currently serves as CEO of Saffron Tech Ltd., an agritech company, and sits on the board of BladeRanger Ltd., a publicly traded Israeli drone payload systems company. Previously, Oster served as Senior Vice President of Mergers and Acquisitions at Alon USA Energy, Inc., leading strategic transactions during the company's growth as a publicly traded energy http://www.streetinsider.com/Management+Changes/BiomX+appoints+Michael+Oster+as+CEO%2C+David+Rokach+as+CFO/26129711.html Mon, 09 Mar 2026 09:00:49 -0400 A.50200987 O.00179827 O.39437095 PHGE http://www.streetinsider.com/Management+Changes/BiomX+appoints+Michael+Oster+as+CEO%2C+David+Rokach+as+CFO/26129711.html <p>BiomX Inc. (NYSE American: PHGE) announced the appointment of Michael Oster as Chief Executive Officer and David Rokach as Chief Financial Officer, according to a company statement.</p> <p>Oster brings experience in corporate strategy, mergers and acquisitions, and operational leadership across energy, infrastructure, and industrial sectors. He currently serves as CEO of Saffron Tech Ltd., an agritech company, and sits on the board of BladeRanger Ltd., a publicly traded Israeli drone payload systems company. Previously, Oster served as Senior Vice President of Mergers and Acquisitions at Alon USA Energy, Inc., leading strategic transactions during the company's growth as a publicly traded energy http://www.streetinsider.com/Management+Changes/BiomX+appoints+Michael+Oster+as+CEO%2C+David+Rokach+as+CFO/26129711.html Mon, 09 Mar 2026 09:00:49 -0400 A.50200987 O.00179827 O.39437095 PHGE http://www.streetinsider.com/Management+Changes/BiomX+appoints+Michael+Oster+as+CEO%2C+David+Rokach+as+CFO/26129711.html <p>BiomX Inc. (NYSE American: PHGE) announced the appointment of Michael Oster as Chief Executive Officer and David Rokach as Chief Financial Officer, according to a company statement.</p> <p>Oster brings experience in corporate strategy, mergers and acquisitions, and operational leadership across energy, infrastructure, and industrial sectors. He currently serves as CEO of Saffron Tech Ltd., an agritech company, and sits on the board of BladeRanger Ltd., a publicly traded Israeli drone payload systems company. Previously, Oster served as Senior Vice President of Mergers and Acquisitions at Alon USA Energy, Inc., leading strategic transactions during the company's growth as a publicly traded energy http://www.streetinsider.com/Management+Changes/BiomX+appoints+Michael+Oster+as+CEO%2C+David+Rokach+as+CFO/26129711.html Mon, 09 Mar 2026 09:00:49 -0400 A.50200987 O.00179827 O.39437095 PHGE http://www.streetinsider.com/Hot+Mgmt+Changes/BiomX+appoints+Michael+Oster+as+CEO%2C+David+Rokach+as+CFO/26129711.html <p>BiomX Inc. (NYSE American: PHGE) announced the appointment of Michael Oster as Chief Executive Officer and David Rokach as Chief Financial Officer, according to a company statement.</p> <p>Oster brings experience in corporate strategy, mergers and acquisitions, and operational leadership across energy, infrastructure, and industrial sectors. He currently serves as CEO of Saffron Tech Ltd., an agritech company, and sits on the board of BladeRanger Ltd., a publicly traded Israeli drone payload systems company. Previously, Oster served as Senior Vice President of Mergers and Acquisitions at Alon USA Energy, Inc., leading strategic transactions during the company's growth as a publicly traded energy http://www.streetinsider.com/Hot+Mgmt+Changes/BiomX+appoints+Michael+Oster+as+CEO%2C+David+Rokach+as+CFO/26129711.html Mon, 09 Mar 2026 09:00:49 -0400 A.50200987 O.00179827 O.39437095 PHGE http://www.streetinsider.com/Hot+Mgmt+Changes/BiomX+appoints+Michael+Oster+as+CEO%2C+David+Rokach+as+CFO/26129711.html <p>BiomX Inc. (NYSE American: PHGE) announced the appointment of Michael Oster as Chief Executive Officer and David Rokach as Chief Financial Officer, according to a company statement.</p> <p>Oster brings experience in corporate strategy, mergers and acquisitions, and operational leadership across energy, infrastructure, and industrial sectors. He currently serves as CEO of Saffron Tech Ltd., an agritech company, and sits on the board of BladeRanger Ltd., a publicly traded Israeli drone payload systems company. Previously, Oster served as Senior Vice President of Mergers and Acquisitions at Alon USA Energy, Inc., leading strategic transactions during the company's growth as a publicly traded energy http://www.streetinsider.com/Hot+Mgmt+Changes/BiomX+appoints+Michael+Oster+as+CEO%2C+David+Rokach+as+CFO/26129711.html Mon, 09 Mar 2026 09:00:49 -0400 A.50200987 O.00179827 O.39437095 PHGE http://www.streetinsider.com/Hot+Mgmt+Changes/BiomX+appoints+Michael+Oster+as+CEO%2C+David+Rokach+as+CFO/26129711.html <p>BiomX Inc. (NYSE American: PHGE) announced the appointment of Michael Oster as Chief Executive Officer and David Rokach as Chief Financial Officer, according to a company statement.</p> <p>Oster brings experience in corporate strategy, mergers and acquisitions, and operational leadership across energy, infrastructure, and industrial sectors. He currently serves as CEO of Saffron Tech Ltd., an agritech company, and sits on the board of BladeRanger Ltd., a publicly traded Israeli drone payload systems company. Previously, Oster served as Senior Vice President of Mergers and Acquisitions at Alon USA Energy, Inc., leading strategic transactions during the company's growth as a publicly traded energy http://www.streetinsider.com/Hot+Mgmt+Changes/BiomX+appoints+Michael+Oster+as+CEO%2C+David+Rokach+as+CFO/26129711.html Mon, 09 Mar 2026 09:00:49 -0400 A.50200987 O.00179827 O.39437095 PHGE http://www.streetinsider.com/Hot+Mgmt+Changes/BiomX+appoints+Michael+Oster+as+CEO%2C+David+Rokach+as+CFO/26129711.html <p>BiomX Inc. (NYSE American: PHGE) announced the appointment of Michael Oster as Chief Executive Officer and David Rokach as Chief Financial Officer, according to a company statement.</p> <p>Oster brings experience in corporate strategy, mergers and acquisitions, and operational leadership across energy, infrastructure, and industrial sectors. He currently serves as CEO of Saffron Tech Ltd., an agritech company, and sits on the board of BladeRanger Ltd., a publicly traded Israeli drone payload systems company. Previously, Oster served as Senior Vice President of Mergers and Acquisitions at Alon USA Energy, Inc., leading strategic transactions during the company's growth as a publicly traded energy http://www.streetinsider.com/Hot+Mgmt+Changes/BiomX+appoints+Michael+Oster+as+CEO%2C+David+Rokach+as+CFO/26129711.html Mon, 09 Mar 2026 09:00:49 -0400 A.50200987 O.00179827 O.39437095 PHGE http://www.streetinsider.com/Press+Releases/BiomX+Names+Michael+Oster+as+Chief+Executive+Officer%2C+David+Rokach+Chief+Financial+Officer+to+Support+Next+Phase+of+Growth/26129676.html <div class="xn-content"> <p class="prntac"><i>Seasoned financial leaders join <span value="AMEX:PHGE" idsrc="xmltag.org" >BiomX</span> to support strategic execution and advancement of the company</i></p><p><span class="legendSpanClass"><location value="LU/us.de.dover" idsrc="xmltag.org" >DOVER, Del.</location> and <location value="LU/il..neszio" idsrc="xmltag.org" >NESS ZIONA, Israel</location></span>, <span class="legendSpanClass"><chron>March 9, 2026</chron></span> /PRNewswire/ -- <a target="_blank" href="https://www.biomx.com/" target="_blank" rel="nofollow"><span value="AMEX:PHGE" idsrc="xmltag.org" >BiomX Inc.</span></a> (NYSE American: PHGE), a clinical-stage company developing natural and engineered phage therapies designed to target and destroy harmful bacteria in chronic diseases, today announced the appointment of <person>Michael Oster</person> as Chief Executive Officer and <person>David Rokach</person> as Chief Financial Officer.</p> <p>Oster brings extensive experience in corporate strategy, mergers and acquisitions, and operational leadership across capital-intensive http://www.streetinsider.com/Press+Releases/BiomX+Names+Michael+Oster+as+Chief+Executive+Officer%2C+David+Rokach+Chief+Financial+Officer+to+Support+Next+Phase+of+Growth/26129676.html Mon, 09 Mar 2026 09:00:00 -0400 A.50200987 O.00179827 O.39437095 PHGE http://www.streetinsider.com/Press+Releases/BiomX+Names+Michael+Oster+as+Chief+Executive+Officer%2C+David+Rokach+Chief+Financial+Officer+to+Support+Next+Phase+of+Growth/26129676.html <div class="xn-content"> <p class="prntac"><i>Seasoned financial leaders join <span value="AMEX:PHGE" idsrc="xmltag.org" >BiomX</span> to support strategic execution and advancement of the company</i></p><p><span class="legendSpanClass"><location value="LU/us.de.dover" idsrc="xmltag.org" >DOVER, Del.</location> and <location value="LU/il..neszio" idsrc="xmltag.org" >NESS ZIONA, Israel</location></span>, <span class="legendSpanClass"><chron>March 9, 2026</chron></span> /PRNewswire/ -- <a target="_blank" href="https://www.biomx.com/" target="_blank" rel="nofollow"><span value="AMEX:PHGE" idsrc="xmltag.org" >BiomX Inc.</span></a> (NYSE American: PHGE), a clinical-stage company developing natural and engineered phage therapies designed to target and destroy harmful bacteria in chronic diseases, today announced the appointment of <person>Michael Oster</person> as Chief Executive Officer and <person>David Rokach</person> as Chief Financial Officer.</p> <p>Oster brings extensive experience in corporate strategy, mergers and acquisitions, and operational leadership across capital-intensive http://www.streetinsider.com/Press+Releases/BiomX+Names+Michael+Oster+as+Chief+Executive+Officer%2C+David+Rokach+Chief+Financial+Officer+to+Support+Next+Phase+of+Growth/26129676.html Mon, 09 Mar 2026 09:00:00 -0400 A.50200987 O.00179827 O.39437095 PHGE http://www.streetinsider.com/Press+Releases/BiomX+Names+Michael+Oster+as+Chief+Executive+Officer%2C+David+Rokach+Chief+Financial+Officer+to+Support+Next+Phase+of+Growth/26129676.html <div class="xn-content"> <p class="prntac"><i>Seasoned financial leaders join <span value="AMEX:PHGE" idsrc="xmltag.org" >BiomX</span> to support strategic execution and advancement of the company</i></p><p><span class="legendSpanClass"><location value="LU/us.de.dover" idsrc="xmltag.org" >DOVER, Del.</location> and <location value="LU/il..neszio" idsrc="xmltag.org" >NESS ZIONA, Israel</location></span>, <span class="legendSpanClass"><chron>March 9, 2026</chron></span> /PRNewswire/ -- <a target="_blank" href="https://www.biomx.com/" target="_blank" rel="nofollow"><span value="AMEX:PHGE" idsrc="xmltag.org" >BiomX Inc.</span></a> (NYSE American: PHGE), a clinical-stage company developing natural and engineered phage therapies designed to target and destroy harmful bacteria in chronic diseases, today announced the appointment of <person>Michael Oster</person> as Chief Executive Officer and <person>David Rokach</person> as Chief Financial Officer.</p> <p>Oster brings extensive experience in corporate strategy, mergers and acquisitions, and operational leadership across capital-intensive http://www.streetinsider.com/Press+Releases/BiomX+Names+Michael+Oster+as+Chief+Executive+Officer%2C+David+Rokach+Chief+Financial+Officer+to+Support+Next+Phase+of+Growth/26129676.html Mon, 09 Mar 2026 09:00:00 -0400 A.50200987 O.00179827 O.39437095 PHGE http://www.streetinsider.com/Press+Releases/BiomX+Names+Michael+Oster+as+Chief+Executive+Officer%2C+David+Rokach+Chief+Financial+Officer+to+Support+Next+Phase+of+Growth/26129676.html <div class="xn-content"> <p class="prntac"><i>Seasoned financial leaders join <span value="AMEX:PHGE" idsrc="xmltag.org" >BiomX</span> to support strategic execution and advancement of the company</i></p><p><span class="legendSpanClass"><location value="LU/us.de.dover" idsrc="xmltag.org" >DOVER, Del.</location> and <location value="LU/il..neszio" idsrc="xmltag.org" >NESS ZIONA, Israel</location></span>, <span class="legendSpanClass"><chron>March 9, 2026</chron></span> /PRNewswire/ -- <a target="_blank" href="https://www.biomx.com/" target="_blank" rel="nofollow"><span value="AMEX:PHGE" idsrc="xmltag.org" >BiomX Inc.</span></a> (NYSE American: PHGE), a clinical-stage company developing natural and engineered phage therapies designed to target and destroy harmful bacteria in chronic diseases, today announced the appointment of <person>Michael Oster</person> as Chief Executive Officer and <person>David Rokach</person> as Chief Financial Officer.</p> <p>Oster brings extensive experience in corporate strategy, mergers and acquisitions, and operational leadership across capital-intensive http://www.streetinsider.com/Press+Releases/BiomX+Names+Michael+Oster+as+Chief+Executive+Officer%2C+David+Rokach+Chief+Financial+Officer+to+Support+Next+Phase+of+Growth/26129676.html Mon, 09 Mar 2026 09:00:00 -0400 A.50200987 O.00179827 O.39437095 PHGE http://www.streetinsider.com/PRNewswire/BiomX+Names+Michael+Oster+as+Chief+Executive+Officer%2C+David+Rokach+Chief+Financial+Officer+to+Support+Next+Phase+of+Growth/26129676.html <div class="xn-content"> <p class="prntac"><i>Seasoned financial leaders join <span value="AMEX:PHGE" idsrc="xmltag.org" >BiomX</span> to support strategic execution and advancement of the company</i></p><p><span class="legendSpanClass"><location value="LU/us.de.dover" idsrc="xmltag.org" >DOVER, Del.</location> and <location value="LU/il..neszio" idsrc="xmltag.org" >NESS ZIONA, Israel</location></span>, <span class="legendSpanClass"><chron>March 9, 2026</chron></span> /PRNewswire/ -- <a target="_blank" href="https://www.biomx.com/" target="_blank" rel="nofollow"><span value="AMEX:PHGE" idsrc="xmltag.org" >BiomX Inc.</span></a> (NYSE American: PHGE), a clinical-stage company developing natural and engineered phage therapies designed to target and destroy harmful bacteria in chronic diseases, today announced the appointment of <person>Michael Oster</person> as Chief Executive Officer and <person>David Rokach</person> as Chief Financial Officer.</p> <p>Oster brings extensive experience in corporate strategy, mergers and acquisitions, and operational leadership across capital-intensive http://www.streetinsider.com/PRNewswire/BiomX+Names+Michael+Oster+as+Chief+Executive+Officer%2C+David+Rokach+Chief+Financial+Officer+to+Support+Next+Phase+of+Growth/26129676.html Mon, 09 Mar 2026 09:00:00 -0400 A.50200987 O.00179827 O.39437095 PHGE http://www.streetinsider.com/PRNewswire/BiomX+Names+Michael+Oster+as+Chief+Executive+Officer%2C+David+Rokach+Chief+Financial+Officer+to+Support+Next+Phase+of+Growth/26129676.html <div class="xn-content"> <p class="prntac"><i>Seasoned financial leaders join <span value="AMEX:PHGE" idsrc="xmltag.org" >BiomX</span> to support strategic execution and advancement of the company</i></p><p><span class="legendSpanClass"><location value="LU/us.de.dover" idsrc="xmltag.org" >DOVER, Del.</location> and <location value="LU/il..neszio" idsrc="xmltag.org" >NESS ZIONA, Israel</location></span>, <span class="legendSpanClass"><chron>March 9, 2026</chron></span> /PRNewswire/ -- <a target="_blank" href="https://www.biomx.com/" target="_blank" rel="nofollow"><span value="AMEX:PHGE" idsrc="xmltag.org" >BiomX Inc.</span></a> (NYSE American: PHGE), a clinical-stage company developing natural and engineered phage therapies designed to target and destroy harmful bacteria in chronic diseases, today announced the appointment of <person>Michael Oster</person> as Chief Executive Officer and <person>David Rokach</person> as Chief Financial Officer.</p> <p>Oster brings extensive experience in corporate strategy, mergers and acquisitions, and operational leadership across capital-intensive http://www.streetinsider.com/PRNewswire/BiomX+Names+Michael+Oster+as+Chief+Executive+Officer%2C+David+Rokach+Chief+Financial+Officer+to+Support+Next+Phase+of+Growth/26129676.html Mon, 09 Mar 2026 09:00:00 -0400 A.50200987 O.00179827 O.39437095 PHGE http://www.streetinsider.com/PRNewswire/BiomX+Names+Michael+Oster+as+Chief+Executive+Officer%2C+David+Rokach+Chief+Financial+Officer+to+Support+Next+Phase+of+Growth/26129676.html <div class="xn-content"> <p class="prntac"><i>Seasoned financial leaders join <span value="AMEX:PHGE" idsrc="xmltag.org" >BiomX</span> to support strategic execution and advancement of the company</i></p><p><span class="legendSpanClass"><location value="LU/us.de.dover" idsrc="xmltag.org" >DOVER, Del.</location> and <location value="LU/il..neszio" idsrc="xmltag.org" >NESS ZIONA, Israel</location></span>, <span class="legendSpanClass"><chron>March 9, 2026</chron></span> /PRNewswire/ -- <a target="_blank" href="https://www.biomx.com/" target="_blank" rel="nofollow"><span value="AMEX:PHGE" idsrc="xmltag.org" >BiomX Inc.</span></a> (NYSE American: PHGE), a clinical-stage company developing natural and engineered phage therapies designed to target and destroy harmful bacteria in chronic diseases, today announced the appointment of <person>Michael Oster</person> as Chief Executive Officer and <person>David Rokach</person> as Chief Financial Officer.</p> <p>Oster brings extensive experience in corporate strategy, mergers and acquisitions, and operational leadership across capital-intensive http://www.streetinsider.com/PRNewswire/BiomX+Names+Michael+Oster+as+Chief+Executive+Officer%2C+David+Rokach+Chief+Financial+Officer+to+Support+Next+Phase+of+Growth/26129676.html Mon, 09 Mar 2026 09:00:00 -0400 A.50200987 O.00179827 O.39437095 PHGE http://www.streetinsider.com/PRNewswire/BiomX+Names+Michael+Oster+as+Chief+Executive+Officer%2C+David+Rokach+Chief+Financial+Officer+to+Support+Next+Phase+of+Growth/26129676.html <div class="xn-content"> <p class="prntac"><i>Seasoned financial leaders join <span value="AMEX:PHGE" idsrc="xmltag.org" >BiomX</span> to support strategic execution and advancement of the company</i></p><p><span class="legendSpanClass"><location value="LU/us.de.dover" idsrc="xmltag.org" >DOVER, Del.</location> and <location value="LU/il..neszio" idsrc="xmltag.org" >NESS ZIONA, Israel</location></span>, <span class="legendSpanClass"><chron>March 9, 2026</chron></span> /PRNewswire/ -- <a target="_blank" href="https://www.biomx.com/" target="_blank" rel="nofollow"><span value="AMEX:PHGE" idsrc="xmltag.org" >BiomX Inc.</span></a> (NYSE American: PHGE), a clinical-stage company developing natural and engineered phage therapies designed to target and destroy harmful bacteria in chronic diseases, today announced the appointment of <person>Michael Oster</person> as Chief Executive Officer and <person>David Rokach</person> as Chief Financial Officer.</p> <p>Oster brings extensive experience in corporate strategy, mergers and acquisitions, and operational leadership across capital-intensive http://www.streetinsider.com/PRNewswire/BiomX+Names+Michael+Oster+as+Chief+Executive+Officer%2C+David+Rokach+Chief+Financial+Officer+to+Support+Next+Phase+of+Growth/26129676.html Mon, 09 Mar 2026 09:00:00 -0400 A.50200987 O.00179827 O.39437095 PHGE http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++BiomX+Inc.++++++++++++++++For%3A+Mar+04/26122726.html si-local-file:///var/storage/secattach/20260306/26122726.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++BiomX+Inc.++++++++++++++++For%3A+Mar+04/26122726.html Fri, 06 Mar 2026 08:55:00 -0400 O.39437095 PHGE http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++BiomX+Inc.++++++++++++++++For%3A+Mar+04/26122726.html si-local-file:///var/storage/secattach/20260306/26122726.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++BiomX+Inc.++++++++++++++++For%3A+Mar+04/26122726.html Fri, 06 Mar 2026 08:55:00 -0400 O.39437095 PHGE http://www.streetinsider.com/SEC+Filings/Form++3++++++++++BiomX+Inc.++++++++++++++++For%3A+Feb+13++Filed+by%3A+Bidas+Liat+Cohavi/26105621.html si-local-file:///var/storage/secattach/20260303/26105621.html http://www.streetinsider.com/SEC+Filings/Form++3++++++++++BiomX+Inc.++++++++++++++++For%3A+Feb+13++Filed+by%3A+Bidas+Liat+Cohavi/26105621.html Tue, 03 Mar 2026 21:28:00 -0400 O.39437095 PHGE